Skip to main content
. Author manuscript; available in PMC: 2018 Aug 1.
Published in final edited form as: Breast Cancer Res Treat. 2017 May 30;165(1):97–107. doi: 10.1007/s10549-017-4292-7

Table 4. Percent breast density (BD) from clinical mammography (4a.) and FWR-MRI-based breast density (range 0-1, higher number indicates higher density) (4b.) baseline and after 12 months on study, by arm.

4a. BD by mammography

Time point Placebo DIME


n Mean ± SD Median n Mean ± SD Median
First mammogram 49 26.3 ± 14.2 23.9 53 23.9 ± 15.5 18.8
Follow-up mammogram 41 25.4 ± 13.9 24.4 45 22.4 ± 15.2 19.2
Change (P = 0.744) a 41 −1.9 ± 7.4 45 −1.3 ± 7.6

4b. BD by FWR MRI

Time point Placebo DIM


n Mean ± SD Median n Mean ± SD Median

Baseline 37 0.32 ± 0.20 0.24 34 0.31 ± 0.26 0.20
12 months 33 0.31 ± 0.18 0.26 27 0.28 ± 0.24 0.20
B to 12 mo (P=0.772)b 30 −0.008 ± 0.1 24 −0.001 ± 0.1
a

t-test for differences in change between placebo and DIM groups

b

Δ B to 12 months = 12 month minus the baseline value